Overview

Conference: February 24-25, 2025 | In-Person

The Advertising and Promotion Regulatory Affairs Conference explores the current state of compliance for marketing both biopharmaceuticals and medical devices. Join thought leaders from industry, legal, public affairs, and government for interactive and compelling discussions that will shape policy and define strategic priorities within the advertising and promotion regulatory space.

This conference is geared towards both early and late-career professionals with content that advances the understanding of current regulatory policies, details the latest strategies for professional development, and discusses the trends in advertising for medical products. You will have the opportunity to network with key thought leaders from the FDA, industry, and other regulatory agencies, while simultaneously discussing the challenges and opportunities of marketing pharmaceuticals and medical devices today.

While we develop our 2025 agenda, please take a moment to review the 2024 final agenda.

Participant Testimonials

It was a great event. The speakers and panels were very informative, relevant, and organizedwell. It was also a wonderful opportunity to network and meet new individuals who work in thesame/similar role at other companies. – James Chang, Associate Manager Regulatory Advertising and Promotion, Astellas

This conference is a great opportunity to learn recent trends in our industry, and hear about exciting issues hot topics. It was so great to see everyone in person again as well and network. – Kavita Vazirani, Principal Consultant, Opus Regulatory, Inc.

All levels of regulatory A&P expertise can benefit from it. Besides educational presentations, the face-to-face social networking aspect of this event was exceptionally good. Breaks after every session helped us refreshed and focused. – Iram Quraishi, Director Regulatory A&P, Takeda

Featured

Want to learn more about Advertising and Promotion Regulatory Affairs Conference? You've come to the right site!

Program Committee

Catherine Gray, PharmD Director, Office of Prescription Drug Promotion, OMP, CDER
FDA, United States
Georgina Lee, PharmD Executive Director, Regulatory Advertising and Promotion
Sage Therapeutics, United States
Alyson Andrikanich, PharmD Senior Director, Advertising and Promotion, Regulatory Affairs Americas
Bayer Pharmaceuticals, United States
Lynn Bowen, PhD Vice President, Regulatory Affairs Advertising Promotion & Labeling
Alkermes, Inc., United States
Bob Dean, MBA Head of Global Labeling Strategy & Ad/Promo
EMD Serono, United States
Anthony Genovese, PharmD Group Leader, Regulatory Advertising and Promotion
Johnson and Johnson, United States
Nicol Lorraine George, PharmD, RPh Vice President, Promotional Review & Labeling Services
ProPharma Group, United States
Joanne Hawana, JD, MS Member
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo P.C., United States
Amy Muhlberg, PhD Deputy Director, OPDP’s Division of Promotion Policy, Research and Operations
FDA, United States
Moulakshi Roychowdhury, JD, PharmD Global Head, Regulatory Affairs, Advertising & Promotion, Allergan Aesthetics
AbbVie, United States
Representative Invited DIA, United States
Dale Cooke, JD, MA President
Phillycooke Consulting, United States
Mark Gaydos Former Global Head, Advertising & Promotion, Global Regulatory Affairs
Sanofi, United States
Micheline Awad, MBA Sr. Director, Regulatory Advertising, Promotion, and Labeling
Day One Biopharmaceuticals, United States